{"transactions":[{"id":4634913,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":47612,"kind":"person","name":"Berkowitz Noah","position":1,"cik":"0001369900","reported_name":"Berkowitz Noah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Performance Stock Units","published_at":"2026-10-03T01:01:05.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance stock unit (\"PSU\") converts into one share of the Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"Up to 135,000 shares of the Issuer's common stock underlying the PSUs may be earned subject to achievement of certain regulatory milestones."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Such earned PSUs shall vest on the date that the Issuer publicly discloses on a Form 8-K with the U.S. Securities and Exchange Commission its receipt of certain regulatory milestones."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Such earned PSUs shall vest on the date that the Issuer publicly discloses on a Form 8-K with the U.S. Securities and Exchange Commission its receipt of certain regulatory milestones."}],"balance_after":135000,"derivative":{"underlying":"Common stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001104659-26-113342","document":"tm2626734-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926113342/tm2626734-2_4seq1.xml","form_type":"4"}},{"id":4634912,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":47612,"kind":"person","name":"Berkowitz Noah","position":1,"cik":"0001369900","reported_name":"Berkowitz Noah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-10-03T01:01:05.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the restricted stock units (\"RSUs\") and options are each exercisable as follows: (i) RSUs and options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining RSUs and options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the restricted stock units (\"RSUs\") and options are each exercisable as follows: (i) RSUs and options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining RSUs and options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."}],"balance_after":180000,"derivative":{"underlying":"Common stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001104659-26-113342","document":"tm2626734-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926113342/tm2626734-2_4seq1.xml","form_type":"4"}},{"id":4634911,"issuer":{"id":2090,"kind":"organization","name":"IOVANCE BIOTHERAPEUTICS, INC.","symbol":"IOVA"},"owners":[{"id":47612,"kind":"person","name":"Berkowitz Noah","position":1,"cik":"0001369900","reported_name":"Berkowitz Noah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-10-03T01:01:05.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Provided the Reporting Person is still employed with the Issuer on the following dates, the restricted stock units (\"RSUs\") and options are each exercisable as follows: (i) RSUs and options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining RSUs and options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant."}],"balance_after":135000,"derivative":{"exercise_price":14.82,"expiration_date":"2036-09-30","underlying":"Common stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001104659-26-113342","document":"tm2626734-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425205/000110465926113342/tm2626734-2_4seq1.xml","form_type":"4"}},{"id":780514,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":47612,"kind":"person","name":"Berkowitz Noah","position":1,"cik":"0001369900","reported_name":"Berkowitz Noah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-13T20:16:06.000Z","date":"2026-05-11","kind":"sale","planned":false,"acquired":false,"shares":11108,"price":9.9374,"value":110384.6392,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-half of the reporting person's restricted stock units (RSUs) granted on May 9, 2025. The sale does not represent a discretionary trade."}],"balance_after":191395,"source":{"system":"sec-edgar","filing":"0001628280-26-034606","document":"wk-form4_1778703361.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369900/000162828026034606/wk-form4_1778703361.xml","form_type":"4"}},{"id":833206,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":47612,"kind":"person","name":"Berkowitz Noah","position":1,"cik":"0001369900","reported_name":"Berkowitz Noah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-20T00:01:54.000Z","date":"2026-03-18","kind":"sale","planned":false,"acquired":false,"shares":6435,"price":11.1004,"value":71431.074,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of 25% of the reporting person's restricted stock units (RSUs) granted on March 18, 2024. The sale does not represent a discretionary trade."}],"balance_after":202503,"source":{"system":"sec-edgar","filing":"0001628280-26-019950","document":"wk-form4_1773964912.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369900/000162828026019950/wk-form4_1773964912.xml","form_type":"4"}},{"id":873678,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":47612,"kind":"person","name":"Berkowitz Noah","position":1,"cik":"0001369900","reported_name":"Berkowitz Noah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-03T01:59:46.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":67000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted by the Issuer on February 26, 2026, pursuant to the Plan. The shares underlying the option vest over four years: one-quarter of the shares underlying the award will vest on February  26, 2027, with the remainder of the shares vesting in equal monthly installments following February 26, 2027 through February 26, 2030, subject to the reporting person's continued service with the  Issuer on each vesting date."}],"balance_after":67000,"derivative":{"exercise_price":13.38,"expiration_date":"2036-02-25","underlying":"Common Stock","underlying_shares":67000},"source":{"system":"sec-edgar","filing":"0001628280-26-013533","document":"wk-form4_1772503183.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1369900/000162828026013533/wk-form4_1772503183.xml","form_type":"4"}},{"id":873677,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":47612,"kind":"person","name":"Berkowitz Noah","position":1,"cik":"0001369900","reported_name":"Berkowitz Noah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-03T01:59:46.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (each, an \"RSU\") were granted by the Issuer on February 26, 2026, pursuant to its 2018 Stock Incentive Plan (the \"Plan\"), and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs will vest over four years: one-quarter of the RSUs will vest on each of February 26, 2027, February 26, 2028, February 26, 2029 and February 26, 2030, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":208938,"source":{"system":"sec-edgar","filing":"0001628280-26-013533","document":"wk-form4_1772503183.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369900/000162828026013533/wk-form4_1772503183.xml","form_type":"4"}},{"id":896035,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":47612,"kind":"person","name":"Berkowitz Noah","position":1,"cik":"0001369900","reported_name":"Berkowitz Noah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-18T23:12:15.000Z","date":"2026-02-13","kind":"sale","planned":false,"acquired":false,"shares":5685,"price":11.89,"value":67594.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of 25% of the reporting person's restricted stock units (RSUs) granted on February 13, 2025. The sale does not represent a discretionary trade."}],"balance_after":163938,"source":{"system":"sec-edgar","filing":"0001628280-26-009300","document":"wk-form4_1771456332.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369900/000162828026009300/wk-form4_1771456332.xml","form_type":"4"}},{"id":1150530,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":47612,"kind":"person","name":"Berkowitz Noah","position":1,"cik":"0001369900","reported_name":"Berkowitz Noah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-05-13T21:15:45.000Z","date":"2025-05-09","kind":"grant","planned":false,"acquired":true,"shares":91000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted by the Issuer on May 9, 2025, pursuant to the Plan. The shares underlying the option will vest over two years: 1/2 of the shares underlying the award shall vest on May 9, 2026, with the remainder of the shares vesting on May 9, 2027, subject to the reporting person's continued service with the Issuer on each vesting date."}],"balance_after":91000,"derivative":{"exercise_price":6.61,"expiration_date":"2035-05-08","underlying":"Common Stock","underlying_shares":91000},"source":{"system":"sec-edgar","filing":"0001655759-25-000087","document":"wk-form4_1747170938.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1369900/000165575925000087/wk-form4_1747170938.xml","form_type":"4"}},{"id":1150529,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":47612,"kind":"person","name":"Berkowitz Noah","position":1,"cik":"0001369900","reported_name":"Berkowitz Noah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-05-13T21:15:45.000Z","date":"2025-05-09","kind":"grant","planned":false,"acquired":true,"shares":59600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (each, an \"RSU\") were granted by the issuer on May 9, 2025, pursuant to its 2018 Stock Incentive Plan (the \"Plan\") and each RSU represents a contingent right to receive one share of the issuer's common stock upon settlement for no consideration. The RSUs will vest over two years: 1/2 of the shares underlying the award shall vest on May 9, 2026, with the remainder of the shares vesting on May 9, 2027, subject to the reporting person's continued service with the Issuer on each vesting date."}],"balance_after":169623,"source":{"system":"sec-edgar","filing":"0001655759-25-000087","document":"wk-form4_1747170938.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369900/000165575925000087/wk-form4_1747170938.xml","form_type":"4"}},{"id":1196856,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":47612,"kind":"person","name":"Berkowitz Noah","position":1,"cik":"0001369900","reported_name":"Berkowitz Noah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-03-19T12:06:56.000Z","date":"2025-03-18","kind":"sale","planned":false,"acquired":false,"shares":8658,"price":8.59,"value":74372.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of 25% of the reporting person's restricted stock units (RSUs) granted on March 18, 2024."}],"balance_after":110023,"source":{"system":"sec-edgar","filing":"0001655759-25-000064","document":"wk-form4_1742386009.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369900/000165575925000064/wk-form4_1742386009.xml","form_type":"4"}},{"id":1263356,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":47612,"kind":"person","name":"Berkowitz Noah","position":1,"cik":"0001369900","reported_name":"Berkowitz Noah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-19T00:57:58.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":84330,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted by the Issuer on February 13, 2025, pursuant to the Plan. The shares underlying the option vest over four years: 1/4 of the shares underlying the award will vest on February  13, 2026, with the remainder of the shares vesting in equal monthly installments following February 13, 2026 through February 13, 2029, subject to the reporting person's continued service with the  Issuer on each vesting date."}],"balance_after":84330,"derivative":{"exercise_price":17.67,"expiration_date":"2035-02-12","underlying":"Common Stock","underlying_shares":84330},"source":{"system":"sec-edgar","filing":"0001655759-25-000023","document":"wk-form4_1739926672.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1369900/000165575925000023/wk-form4_1739926672.xml","form_type":"4"}},{"id":1263355,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":47612,"kind":"person","name":"Berkowitz Noah","position":1,"cik":"0001369900","reported_name":"Berkowitz Noah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-19T00:57:58.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":55229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (each, an \"RSU\") were granted by the issuer on February 13, 2025, pursuant to its 2018 Stock Incentive Plan (the \"Plan\") and each RSU represents a contingent right to receive one share of the issuer's common stock upon settlement for no consideration. The RSUs will vest over four years: 25% of the RSUs will vest on each of February 13, 2026, February 13, 2027, February 13, 2028 and February 13, 2029, subject to the reporting person's continued service with the  Issuer on each vesting date."}],"balance_after":118681,"source":{"system":"sec-edgar","filing":"0001655759-25-000023","document":"wk-form4_1739926672.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369900/000165575925000023/wk-form4_1739926672.xml","form_type":"4"}},{"id":1564622,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":47612,"kind":"person","name":"Berkowitz Noah","position":1,"cik":"0001369900","reported_name":"Berkowitz Noah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-21T20:15:02.000Z","date":"2024-03-18","kind":"grant","planned":false,"acquired":true,"shares":93879,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted by the Issuer on March 18, 2024, in accordance with Nasdaq Listing Rule 5635(c)(4) and not pursuant the Plan. The shares underlying the option will vest over four years: 1/4 of the shares underlying the award shall vest on March 18, 2025, with the remainder of the shares vesting in equal monthly installments following March 18, 2025 through March 18, 2028."}],"balance_after":93879,"derivative":{"exercise_price":42.6,"expiration_date":"2034-03-17","underlying":"Common Stock","underlying_shares":93879},"source":{"system":"sec-edgar","filing":"0001655759-24-000040","document":"wk-form4_1711052087.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1369900/000165575924000040/wk-form4_1711052087.xml","form_type":"4"}},{"id":1564621,"issuer":{"id":5355,"kind":"organization","name":"ARVINAS, INC."},"owners":[{"id":47612,"kind":"person","name":"Berkowitz Noah","position":1,"cik":"0001369900","reported_name":"Berkowitz Noah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-03-21T20:15:02.000Z","date":"2024-03-18","kind":"grant","planned":false,"acquired":true,"shares":63452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (each, an \"RSU\") were granted by the Issuer on March 18, 2024, in accordance with Nasdaq Listing Rule 5635(c)(4), and not pursuant to its 2018 Stock Incentive Plan (the \"Plan\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs will vest over four years: 25% of the RSUs will vest on each of March 18, 2025,  March 18, 2026, March 18, 2027 and  March 18, 2028, subject to the Reporting Person's continued service with the Issuer on each such vesting date."}],"balance_after":63452,"source":{"system":"sec-edgar","filing":"0001655759-24-000040","document":"wk-form4_1711052087.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369900/000165575924000040/wk-form4_1711052087.xml","form_type":"4"}}]}